The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Guidelines for the Selection of Anti-infective Agents for Complicated Intra-abdominal Infections
Open accessAbstract
These guidelines, from the Infectious Diseases Society of America (IDSA), the Surgical Infection Society, the American Society for Microbiology, and the Society of Infectious Disease Pharmacists, contain evidence-based recommendations for selection of antimicrobial therapy for adult patients with complicated intra-abdominal infections. Complicated intra-abdominal infections extend beyond the hollow viscus of origin into the peritoneal space and are associated either with abscess formation or with peritonitis. These guidelines also address timing of initiation of antibiotic therapy, when and what to culture, modification of therapy based on culture results, and duration of therapy. Infecting flora. The anticipated infecting flora in these infections and, therefore, the agent(s) selected are determined by whether the infection is community acquired or health care associated. Health care–associated intra-abdominal infections are most commonly acquired as complications of previous elective or emergent intra-abdominal operations and are caused by nosocomial isolates particular to the site of the operation and to the specific hospital and unit. For community-acquired infections, the location of the gastrointestinal perforation (stomach, duodenum, jejunum, ileum, appendix, or colon) defines the infecting flora. Established infection beyond the proximal small bowel is caused by facultative and aerobic gram-negative organisms; infections beyond the proximal ileum also can be caused by a variety of anaerobic microorganisms. Microbiologic evaluation. Given the activity of common regimens against the anaerobic organisms identified in community-acquired infections, microbiologic workup for specimens from such infections should be limited to identification and susceptibility testing of facultative and aerobic gram-negative bacilli. Susceptibility profiles for Bacteroides fragilis group isolates demonstrate substantial resistance to clindamycin, cefotetan, cefoxitin, and quinolones, and these agents should not be used alone empirically in contexts in which B. fragilis is likely to be encountered. Recommended regimens. These infections may be managed with a variety of single- and multiple-agent regimens. The antimicrobials and combinations of antimicrobials listed in table 1 are considered appropriate for the treatment of community-acquired intra-abdominal infections. No regimen has been consistently demonstrated to be superior or inferior. Although many of the listed regimens have been studied in prospective clinical trials, many such studies have serious design flaws. Recommendations are, therefore, based in part on in vitro activities. Recommended agents for treatment of community-acquired complicated intra-abdominal infections. Community-acquired infections. For patients with community-acquired infections of mild-to-moderate severity, agents that have a narrower spectrum of activity and that are not commonly used for nosocomial infections, such as ampicillin/sulbactam, cefazolin or cefuroxime plus metronidazole, ticarcillin/clavulanate, ertapenem, and quinolones plus metronidazole, are preferable to agents that have broader coverage against gram-negative organisms and/or greater risk of toxicity. Cost is an important factor in the selection of a specific regimen. Patients with more-severe infections, as defined by accepted physiologic scoring systems, or patients deemed to have immunosuppression resulting either from medical therapy or from acute or chronic disease, might benefit from regimens with a broader spectrum of activity against facultative and aerobic gram-negative organisms. Recommended regimens include meropenem, imipenem/cilastatin, third- or fourth-generation cephalosporins (cefotaxime, ceftriaxone, ceftizoxime, ceftazidime, and cefepime) plus metronidazole, ciprofloxacin plus metronidazole, and piperacillin/tazobactam. Health care–associated infections. Postoperative (nosocomial) infections are caused by more-resistant flora, which may include Pseudomonas aeruginosa, Enterobacter species, Proteus species, methicillin-resistant Staphylococcus aureus, enterococci, and Candida species. For these infections, complex multidrug regimens are recommended, because adequate empirical therapy appears to be important in reducing mortality. Local nosocomial resistance patterns should dictate empirical treatment, and treatment should be altered on the basis of the results of a thorough microbiologic workup of infected fluid. These infections remain an important area for clinical research. Multiple implementation strategies should be used to maximize adherence to these recommendations. These include obtaining feedback from microbiologists, nurses, pharmacists, and physicians before local publication of selected regimens; use of lectures and publications; small-group interactive sessions; and computer-assisted care. Compliance may be monitored through pharmacy-based drug utilization reviews and through review of microbio
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shlaes, D. M., Gerding, D. N., John, Jr., Craig, W. A., Bornstein, D. L., Duncan, R. A., Eckman, M. R., Farrer, W. E., Greene, W. H., Lorian, V., et al. (1997) · Clinical Infectious Diseases · doi:10.1086/513766 · Cited by 780
Montravers, P., Gauzit, R., Muller, C., Marmuse, J. P., Fichelle, A., & Desmonts, J. M. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.3.486 · Cited by 329
Antibiotic Treatment for Surgical Peritonitis
MOSDELL, D. M., MORRIS, D. M., VOLTURA, A., PITCHER, D. E., TWIEST, M. W., MILNE, R. L., MISCALL, B. G., & FRY, D. E. (1991) · Annals of Surgery · doi:10.1097/00000658-199111000-00001 · Cited by 280
Guide to Development of Practice Guidelines
Kish, M. A. (2001) · Clinical Infectious Diseases · doi:10.1086/319366 · Cited by 276
Bohnen, J. M. A. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420010097015 · Cited by 266
CLINICAL SIGNIFICANCE OF CANDIDA ISOLATED FROM PERITONEUM IN SURGICAL PATIENTS
Calandra, T., Schneider, R., Bille, J., Mosimann, F., & Francioli, P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92043-6 · Cited by 239
Christou, N. V. (1993) · Archives of Surgery · doi:10.1001/archsurg.1993.01420140070011 · Cited by 227
Rau, B., Pralle, U., Mayer, J. M., & Beger, H. G. (1998) · Journal of British Surgery · doi:10.1046/j.1365-2168.1998.00707.x · Cited by 220
Nguyen, M. H., Yu, V. L., Morris, A. J., McDermott, L., Wagener, M. W., Harrell, L., & Snydman, D. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313805 · Cited by 215
SOLOMKIN, J. S., DELLINGER, E. P., CHRISTOU, N. V., & BUSUTTIL, R. W. (1990) · Annals of Surgery · doi:10.1097/00000658-199011000-00004 · Cited by 205
Self-citationMazuski, J. E., Sawyer, R. G., Nathens, A. B., DiPiro, J. T., Schein, M., Kudsk, K. A., & Yowler, C. (2002) · Surgical Infections · doi:10.1089/109629602761624171 · Cited by 202
Self-citationRisk factors associated with intraabdominal infections: a prospective multicenter study
Wacha, H., Hau, T., Dittmer, R., & Ohmann, C. (1999) · Langenbeck's Archives of Surgery · doi:10.1007/s004230050169 · Cited by 200
Surgical Infection Stratification System for Intra-abdominal Infection: Multicenter Trial
Dellinger, E. P. (1985) · Archives of Surgery · doi:10.1001/archsurg.1985.01390250015003 · Cited by 198
Self-citationThe role of Candida in intraperitoneal infections.
Solomkin, J. S., Flohr, A. B., Quie, P. G., & Simmons, R. L. (1980) · PubMed · Cited by 195
Self-citationSolomkin, J. S., Reinhart, H. H., Dellinger, E. P., Bohnen, J. M., Rotstein, O. D., Vogel, S. B., Simms, H. H., Hill, C. S., Bjornson, H. S., Haverstock, D. C., et al. (1996) · Annals of Surgery · doi:10.1097/00000658-199603000-00012 · Cited by 192
Self-citationSolomkin, J. S., Yellin, A. E., Rotstein, O. D., Christou, N. V., Dellinger, E. P., Tellado, J. M., Malafaia, O., Fernandez, A., Choe, K. A., Carides, A., et al. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000048551.32606.73 · Cited by 182
Self-citationDoes antibiotic restriction prevent resistance?
Je, M., & Dn, G. (1996) · PubMed · Cited by 161
Jaccard, C., Troillet, N., Harbarth, S., Zanetti, G., Aymon, D., Schneider, R., Chiolero, R., Ricou, B., Romand, J., Huber, O., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2966 · Cited by 160
Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation
Cuchural, G. J., Tally, F. P., Jacobus, N. V., Aldridge, K. E., Cleary, T., Finegold, S. M., Hill, G. B., Iannini, P. B., O'Keefe, J. P., & Pierson, C. L. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.5.717 · Cited by 143
Barie, P. S. (1997) · Archives of Surgery · doi:10.1001/archsurg.1997.01430360040008 · Cited by 140
Mazuski, J. E., Sawyer, R. G., Nathens, A. B., DiPiro, J. T., Schein, M., Kudsk, K. A., & Yowler, C. (2002) · Surgical Infections · doi:10.1089/109629602761624180 · Cited by 131
Self-citationWestphal, J.-F., & Brogard, J. (1999) · Drugs · doi:10.2165/00003495-199957010-00007 · Cited by 130
Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections
Brismar, B., Malmborg, A. S., Tunevall, G., Wretlind, B., Bergman, L., Mentzing, L. O., Nyström, P. O., Kihlström, E., Bäckstrand, B., & Skau, T. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2766 · Cited by 130
Snydman, D. R., Jacobus, N. V., McDermott, L. A., Supran, S. E., Cuchural, G. J., Finegold, S. M., Harrell, L. J., Hecht, D. W., Iannini, P. B., Jenkins, S. G., et al. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2417 · Cited by 105
Self-citationSnydman, D. R., Jacobus, N. V., McDermott, L. A., Ruthazer, R., Goldstein, E. J. C., Finegold, S. M., Harrell, L. J., Hecht, D. W., Jenkins, S. G., Pierson, C. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/341934 · Cited by 103
Self-citationChristou, N. V., Turgeon, P., Wassef, R., Rotstein, O., Bohnen, J., & Potvin, M. (1996) · Archives of Surgery · doi:10.1001/archsurg.1996.01430230075014 · Cited by 102
Cohn, S. M., Lipsett, P. A., Buchman, T. G., Cheadle, W. G., Milsom, J. W., O'Marro, S. D., Yellin, A. E., Jungerwirth, S., Rochefort, E. V., Haverstock, D. C., et al. (2000) · Annals of Surgery · doi:10.1097/00000658-200008000-00016 · Cited by 95
Self-citationDiagnosis of Strep Throat in Adults: Are Clinical Criteria Really Good Enough?
Bisno, A. L., Peter, G. S., & Kaplan, E. L. (2002) · Clinical Infectious Diseases · doi:10.1086/342056 · Cited by 94
Lennard, E. S., Dellinger, E. P., Wertz, M. J., & Minshew, B. H. (1982) · Annals of Surgery · doi:10.1097/00000658-198201001-00003 · Cited by 93
Self-citationFalagas, M. E., Barefoot, L., Griffith, J., Ruthazar, R., & Snydman, D. R. (1996) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01690508 · Cited by 92
Prospective evaluation of prognostic scoring systems in peritonitis. Peritonitis Study Group.
Ohmann, C., Wittmann, D. H., & Wacha, H. (1993) · PubMed · Cited by 92
Cellular immunity to Bacteroides fragilis capsular polysaccharide.
SHAPIRO, M. E., Onderdonk, A. B., Kasper, D. L., & Finberg, R. W. (1982) · The Journal of Experimental Medicine · doi:10.1084/jem.155.4.1188 · Cited by 89
Yellin, A. E., Pn, H., Tv, B., Appleman, M. D., Gill, M. A., Ce, R., & Chenella, F. C. (1985) · PubMed · Cited by 84
Wilton, P., Smith, R., Coast, J., & Millar, M. R. (2002) · Journal of Health Services Research & Policy · doi:10.1258/1355819021927764 · Cited by 79
Kokoska, E. R., Silen, M. L., Tracy, T. F., Dillon, P. A., Kennedy, D. J., Cradock, T. V., & Weber, T. R. (1999) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(99)90368-8 · Cited by 76
Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections
Brismar, B., Malmborg, A. S., Tunevall, G., Lindgren, V., Bergman, L., Mentzing, L. O., Nyströdm, P. O., Ånséhn, S., Bäckstrand, B., Skau, T., et al. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.1.139 · Cited by 74
Efficacy of a β-Lactamase Inhibitor Combination for Serious Intra-abdominal Infections
Walker, A. P., Nichols, R. L., Wilson, R. F., Bivens, B. A., Trunkey, D. D., Edmiston, C. E., Smith, J. W., & Condon, R. E. (1993) · Annals of Surgery · doi:10.1097/00000658-199302000-00004 · Cited by 73
Polk, H. C., Fink, M. P., Laverdière, M., Wilson, S. E., Garber, G. E., Barie, P. S., Hebert, J. C., & Cheadle, W. G. (1993) · PubMed · Cited by 71
Condon, R. E., Walker, A. P., Sirinek, K. R., White, P. W., Fabian, T. C., Nichols, R. L., & Wilson, S. E. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.3.544 · Cited by 68
Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgery
Geroulanos, S., & the Meropenem Study Group (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.suppl_a.191 · Cited by 66
Taylor, E., Dev, V., Shah, D. S., Festekjian, J. H., & Gaw, F. (2000) · The American Surgeon · doi:10.1177/000313480006600919 · Cited by 65
Evaluation of New Anti-Infective Drugs for the Treatment of Intraabdominal Infections
Solomkin, J. S., Hemsell, D. L., Sweet, R. L., Tally, F., & Bartlett, J. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.supplement_1.s33 · Cited by 65
Self-citationAntibiotic monotherapy with meropenem in the surgical management of intra-abdominal infections
Huizinga, W. K. J., Warren, B. L., Baker, L. W., Valleur, P. D., Pezet, D., Hoogkamp-Korstanje, J. A. A., & Karran, S. J. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.suppl_a.179 · Cited by 61
Solomkin, J. S., Wilson, S. E., Christou, N. V., Rotstein, O. D., Dellinger, E. P., Bennion, R. S., Pak, R. C. K., & Tack, K. J. (2001) · Annals of Surgery · doi:10.1097/00000658-200101000-00013 · Cited by 59
Self-citationOhlin, B. (1999) · The European Journal of Surgery · doi:10.1080/11024159950189393 · Cited by 56
Snydman, D. R., Cuchural, G. J., McDermott, L. A., & Gill, M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.3.540 · Cited by 55
Is Abdominal Cavity Culture of Any Value in Appendicitis?
Bilik, R., Burnweit, C. A., & Shandling, B. (1998) · The American Journal of Surgery · doi:10.1016/s0002-9610(98)00019-1 · Cited by 51
Bacteria and septic complications in patients with perforated duodenal ulcers
Boey, J., Wong, J., & Ong, G. B. (1982) · The American Journal of Surgery · doi:10.1016/0002-9610(82)90182-9 · Cited by 46
Basoli, A., Meli, E. Z., Mazzocchi, P., Speranza, V., & Study Group (1997) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549709011863 · Cited by 40
Imipenem versus tobramycin--antianaerobe antibiotic therapy in intra-abdominal infections.
Poenaru, D., Santis, M. D., & Nv, C. (1990) · PubMed · Cited by 38
Berne, T. V., Yellin, A. E., Appleman, M. D., Heseltine, P. N. R., & Gill, M. A. (1996) · PubMed · Cited by 38
Donahue, P. E., Smith, D. L., Yellin, A. E., Mintz, S. J., Bur, F., & Luke, D. R. (1998) · The American Journal of Surgery · doi:10.1016/s0002-9610(98)00221-9 · Cited by 36
Sirinek, K. R., & Levine, B. A. (1991) · PubMed · Cited by 35
Cephalosporin therapy in intraabdominal infections
Wilson, S. E., Boswick, J. A., Duma, R. J., ECHOLS, R. M., Jemsek, J. G., Lerner, R., Lewis, R. T., Najem, A. Z., Press, R. A., Rittenbury, M. S., et al. (1988) · The American Journal of Surgery · doi:10.1016/s0002-9610(88)80215-0 · Cited by 34
Aldridge, K. E., & O'Brien, M. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.11.4349-4352.2002 · Cited by 34
Mehtar, S. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/39.5.631 · Cited by 33
Candida and perforated peptic ulcers.
Jb, P. (1986) · PubMed · Cited by 32
Dougherty, S. H., Sirinek, K. R., Schauer, P. R., Fink, M. P., Fabian, T. C., Martin, D. H., & Wiedermann, B. (1995) · PubMed · Cited by 31
Luke, M., Iversen, J., Søndergaard, J., Kvist, E., Lund, P., Andersen, F., Naver, L., Larsen, P. N., Clausen, B., & Prag, J. (1991) · PubMed · Cited by 27
Angerås, M. H., Darle, N., Hamnström, K., Ekelund, M., Engström, L., Takala, J. A., Viste, A., & Holme, J. B. (1996) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549609037950 · Cited by 26
Leukocytosis at Termination of Antibiotic Therapy
Lennard, E. S. (1980) · Archives of Surgery · doi:10.1001/archsurg.1980.01380080016003 · Cited by 25
Allo, M. D., Bennion, R. S., Kathir, K., Thompson, J. E., Lentz, M., Meute, M., & Finegold, S. M. (1999) · The American Surgeon · doi:10.1177/000313489906500201 · Cited by 25
Septic complications of perforated peptic ulcer.
Fong, I. W. (1983) · PubMed · Cited by 21
Clinical importance of cefoxitin-resistant Bacteroides fragilis isolates
Bieluch, V. M., Cuchural, G. J., Snydman, D. R., et al. (1987) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(87)90029-0 · Cited by 13
Cited by
Solomkin, J. S., Mazuski, J. E., Bradley, J. S., Rodvold, K. A., Goldstein, E. J. C., Baron, E. J., O'Neill, P. J., Chow, A. W., Dellinger, E. P., Eachempati, S. R., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649554 · Cited by 1,558
Self-citationCalandra, T., & Cohen, J. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000168253.91200.83 · Cited by 839
Miller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gilligan, P. H., Gonzalez, M. D., Jerris, R. C., Kehl, S. C., Patel, R., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy381 · Cited by 641
Solomkin, J. S., Mazuski, J. E., Bradley, J. S., Rodvold, K. A., Goldstein, E. J. C., Baron, E. J., O'Neill, P. J., Chow, A. W., Dellinger, E. P., Eachempati, S. R., et al. (2010) · Surgical Infections · doi:10.1089/sur.2009.9930 · Cited by 623
Self-citationBaron, E. J., Miller, J. M., Weinstein, M. P., Richter, S. S., Gilligan, P. H., Thomson, R. B., Bourbeau, P., Carroll, K. C., Kehl, S. C., Dunne, W. M., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit278 · Cited by 592
Self-citation
Metadata
- Authors
- Solomkin, J. S., Mazuski, J. E., Baron, E. J., Sawyer, R. G., Nathens, A. B., DiPiro, J. T., Buchman, T., Dellinger, E. P., Jernigan, J., Gorbach, S., Chow, A. W., & Bartlett, J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-10-15
- Volume
- 37
- Issue
- 8
- Pages
- 997-1005
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2116352191
- Cited by
- 515
- References
- 64
- FWCI
- 21.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.